A Pharmacoepidemiological Approach to Evaluate Drug-Drug Interactions in a Specialized Stroke Unit in Pakistan

被引:0
|
作者
Shakeel, Faisal [1 ]
Khan, Jamshaid A. [2 ]
Aamir, Muhammad [2 ]
机构
[1] Sarhad Univ Sci & IT, Dept Pharm, Peshawar, Pakistan
[2] Univ Peshawar, Dept Pharm, Peshawar, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2018年 / 37卷 / 09期
关键词
clinical pharmacy; drug-drug interactions; stroke; GLOBAL BURDEN; RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stroke is one of the common diseases responsible for morbidity and mortality worldwide, despite advancements in its treatment and management through drug therapy or surgical intervention. Drug interactions in stroke patients present a unique challenge as the patient's critical condition makes concomitant drug administration risky. The aim was to determine the prevalence of potential drug-drug interactions, and to identify clinically significant drug-drug interactions. The cross sectional one-year study was carried out in a stroke unit of a tertiary care hospital. Patient medication charts were evaluated for potential drug-drug interactions using Micromedex DrugReax. Statistical analysis was carried out using IBM SPSS Statistics for Windows. A 70.8% prevalence of potential drug-drug interactions was observed in the patients of stroke unit. Clinically significant interactions were present in 58.2% patients which was attributed to 58 drug pairs. A significant association was present between number of interactions and number of prescribed drugs and age.
引用
收藏
页码:1882 / 1887
页数:6
相关论文
共 50 条
  • [31] Drug-drug interactions of β-adrenoceptor blockers
    Brodde, OE
    Kroemer, HK
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2003, 53 (12): : 814 - 822
  • [32] A Message Passing Approach to Biomedical Relation Classification for Drug-Drug Interactions
    Zaikis, Dimitrios
    Karalka, Christina
    Vlahavas, Ioannis
    APPLIED SCIENCES-BASEL, 2022, 12 (21):
  • [33] Drug-drug interactions.: An update
    Morales-Olivas, Francisco J.
    Estan, Luis
    MEDICINA CLINICA, 2006, 127 (07): : 269 - 275
  • [34] Drug-Drug Interactions in Headache Medicine
    Ansari, Hossein
    Ziad, Sanaz
    HEADACHE, 2016, 56 (07): : 1241 - 1248
  • [35] Evaluation of drug-drug interactions with fesoterodine
    Malhotra, Bimal
    Sachse, Richard
    Wood, Nolan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (06) : 551 - 560
  • [36] Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020
    Jiang, Huaqiao
    Lin, Yanhua
    Ren, Weifang
    Fang, Zhonghong
    Liu, Yujuan
    Tan, Xiaofang
    Lv, Xiaoqun
    Zhang, Ning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Evaluation of Potential Drug-Drug Interactions Caused by Antibacterial and Antifungal Drugs in the Intensive Care Unit: A Retrospective Cross-Sectional Study
    Benligil, Seyda
    Demirpolat, Eren
    Kilic, Aysegul Ulu
    Gundogan, Kursat
    JOURNAL OF CLINICAL PRACTICE AND RESEARCH, 2023, 45 (06): : 605 - 613
  • [38] Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay
    Sanchez, Lydia
    Bacle, Astrid
    Lamy, Thierry
    Le Corre, Pascal
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 827 - 835
  • [39] Measuring drug similarity using drug-drug interactions
    Lv, Ji
    Liu, Guixia
    Ju, Yuan
    Huang, Houhou
    Sun, Ying
    QUANTITATIVE BIOLOGY, 2024, 12 (02) : 164 - 172
  • [40] Renal drug transporters and their significance in drug-drug interactions
    Yin, Jia
    Wang, Joanne
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (05) : 363 - 373